Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...
The US Food and Drug Administration (FDA) issued a safety alert this week to highlight a nationwide recall of irbesartan tablets manufactured by Sciegen Pharmaceuticals. The medication is being ...
Of the 159 patients who entered the study, 124 were randomized ( Table 1). AER was significantly reduced (P < 0.01) at the end of irbesartan treatment in both hypertensive (mean change from baseline ...
(CNN) -- The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high blood pressure, for a potential cancer risk due to contamination. This time, SciGen ...
An unmet need exists for focal segmental glomerulosclerosis (FSGS) treatment. In an 8-week, phase 2 trial, sparsentan, a dual endothelin–angiotensin receptor antagonist, reduced proteinuria in ...
Please provide your email address to receive an email when new articles are posted on . Patients treated with maximally titrated irbesartan had slower decline in kidney function. Patients treated with ...
Learn the correct pronunciation of the Irbesartan and Hydrochlorothiazide , understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, ...
Combination therapy using irbesartan and hydrochlorothiazide was shown to effectively lower blood pressure levels in a large group of hypertensive patients. “The INCLUSIVE [Irbesartan/HCTZ blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results